pharma antitrust
FTC and Surescripts Reach Settlement of E-Prescription Monopolization Case
Proposed agreement follows court ruling on Surescripts’ dominant 95% “supershare.” Health information technology company Surescripts, LLC has agreed to stop engaging in exclusionary conduct…
Pfizer Completes $5.4 Billion Acquisition of Sickle Cell Disease Drug Innovator
Pfizer Inc. has acquired Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company whose leading product inhibits harmful medical conditions that lead to the relatively…